DECC (dexamethasone, etoposide, chlorambucil, lomustine) as an oral chemotherapy regimen in relapsed and refractory diffuse large B‐cell lymphoma

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 192; no. 3; pp. e92 - e94
Main Authors Maddox, Jamie M., Horan, Matthew, Tafesh, Laith, Shrubsole, Caroline, Osborne, Wendy
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2021
Subjects
B-cell lymphoma
Chemotherapy
Chlorambucil
clinical haematology
Dexamethasone
Etoposide
Hematology
Non‐Hodgkin lymphoma
Non-Hodgkin lymphoma
clinical haematology
chemotherapy
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.17278